Form 4 for PRVA Privia Health Group, Inc.
Accepted 2026-05-13 18:10:21 ET · period of report 2026-05-11 · accession 0001858396-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 18:10 | 2026-05-11 | PRVA | Mountcastle David | EVP, CFO | S - Sale | $22.60 | -3,385 | 211.5K | -2% | -$76.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2026-05-11 | S | D | 3,385 | $22.60 | 211,462 | D | — | — | (F1) The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. |